Minerva Neurosciences (NERV) Other Working Capital Changes (2015 - 2018)
Minerva Neurosciences (NERV) posted Other Working Capital Changes of -$1086.0 for Q4 2018, down 83.45% on a QoQ basis from -$592.0 in Q3 2018, and up 100.0% year-over-year from -$543.01 in Q4 2017.
Minerva Neurosciences (NERV) Other Working Capital Changes (2015 - 2018) Analysis & Trends
Minerva Neurosciences' Other Working Capital Changes history runs 2 years deep, the most recent figure standing at $37.1 million for Q3 2017.
- Quarterly Other Working Capital Changes rose 100.0% year-over-year to -$1086.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$888.0 (up 100.0% YoY) and the FY2018 annual result came in at -$888.0, down 102.97% from the prior year.
- Other Working Capital Changes was -$1086.0 for Q4 2018 at Minerva Neurosciences, down from -$592.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $395.0 in Q1 2018 and bottomed at -$41.1 million in Q4 2017.
- A 3-year average of -$5.1 million and a median of -$1825.0 in 2015 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 100.0% in 2018, while the deepest fall reached 100.0% in 2018.
- Minerva Neurosciences' Other Working Capital Changes stood at -$2565.0 in 2015, then slumped by 1604021.72% to -$41.1 million in 2017, then jumped by 100.0% to -$1086.0 in 2018.
- Business Quant data shows NERV's Other Working Capital Changes at -$1086.0 in Q4 2018, -$592.0 in Q3 2018, and $395.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -1,086.00 |
| Dec 31, 2018 | -1,086.00 |
| Dec 31, 2018 | -1,086.00 |
| Sep 30, 2018 | -592.00 |
| Sep 30, 2018 | -592.00 |
| Sep 30, 2018 | -592.00 |
| Jun 30, 2018 | 395.00 |
| Jun 30, 2018 | 395.00 |
| Jun 30, 2018 | 395.00 |
| Mar 31, 2018 | 395.00 |
| Mar 31, 2018 | 395.00 |
| Mar 31, 2018 | 395.00 |
| Dec 31, 2017 | -41.15 Mn |
| Dec 31, 2017 | -41.15 Mn |
| Dec 31, 2017 | -41.15 Mn |
| Sep 30, 2015 | -2,565.00 |
| Sep 30, 2015 | -2,565.00 |
| Sep 30, 2015 | -2,565.00 |
| Jun 30, 2015 | -2,564.00 |
| Jun 30, 2015 | -2,564.00 |